- Joslin Diabetes Center – Boston, MA.
License and Development Agreement relating to Type 1 diabetes immunotherapeutics
Placebo controlled Phase 1 clinical study sponsored by the Immune Tolerance Network/NIAID completed
- Nova Laboratories PLC – U.K.
2010 Equity and Technology Transfer Agreement – Nova acquired an equity interest in Mercia and granted Mercia a license for use of trehalose antigen-stabilization technology (AST) with MERIT based products.
2004 Manufacturing Agreement – Mutually exclusive partnership between Mercia and Nova for GMP-compliant manufacturing of therapeutic products based on MERIT technology.
- Asthma and Allergy – NIH grant # 1 R41 A1074114 “Therapeutic Vaccine for Asthma”.
PI P. Blackburn, Ph.D. A collaboration with Dr. Gabriele Grunig, NYU School of Environmental Medicine
- Influenza – NIH grant # 1 R43 A1074119 “Adjuvanted Influenza vaccine”.
PI P. Blackburn, Ph.D. A collaboration with Dr.John Treanor University of Rochester, NY.